Abstract
Introduction Analysis of cough sounds have the potential to give a clue regarding the underlying respiratory disease. The SaaS® platform using artificial intelligence technology can analyze the cough sounds.
Methods Patients (age >= 18 years) presenting to our departments with respiratory symptoms were prospectively recruited into the study. Patients cough sound was recorded by a mobile device in which the Swaasa software was installed. Spirometry was done and patients’ clinical diagnosis is taken as reference standard for comparison. Polychotomous variables were analyzed in binary form as normal and abnormal. Multi-class outcomes were defined as obstructive, restrictive, or normal spirometry, mild-moderate-severe impairment of spirometry values or disease conditions like asthma, COPD, ILD, Bronchiectasis.
Results We recruited 2179 patients with respiratory diseases and 827 normal individuals. Sixty-two percent of them were males. The Swaasa platform has 90% accuracy in distinguishing cough from normal individuals and patients as well as distinguishing normal from abnormal spirometry. The performance was consistent across demographic parameters such as age, gender, and BMI. Its accuracy in differentiating into various severity subtypes of spirometry as well as disease types can be improved further.
Conclusion Swaasa® commends an elevated level of precision in classifying normal and abnormal conditions across demographic subgroups indicating its promise as a screening tool. While the accuracy measures emphasize further refinement to ensure consistent high performance across disease scenarios and severity levels, the study shows Swaasa®’s reasonable potential in identification of specific respiratory diseases and their severity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study is funded by IHC
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The IRB of Christian Medical College, Vellore, India gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
